공공의료 종합병원에서 5대 소화기암 환자의 건강보험 유형에 따른 예후 분석: 단일기관, 후향적 연구 = Analysis of Prognosis according to Type of Health Insurance in Five Major Gastrointestinal Cancer Patients in Public Hospitals: Single-institution Retrospective Study

다국어 초록 (Multilingual Abstract)

Background/Aims: Public hospitals were established to provide high quality medical services to low socioeconomic status patients. This study examined the effects of public hospitals on the treatment and prognosis of patients with five-major gastrointestinal (GI) cancers (stomach cancer, colon cancer, liver cancer, bile duct cancer, and pancreatic cancer).
Methods: Among the 1,268 patients treated at Seoul National University Boramae Medical Center from January 2010 to December 2017, 164 (13%) were in the medicare group. The data were analyzed to identify and compare the clinical manifestations, treatment modality, and clinical outcomes between the groups.
Results: No statistically significant differences in the clinical data (age, sex), treatment method, and five-year survival rate were observed between the health insurance group and medicare group in the five major GI cancer patients. On the other hand, some medicare group patients tended more comorbidities and fewer treatment options than health insurance patients.
Conclusions: Public hospitals have a positive effect on the treatment and prognosis in medicare group patients with the five-major GI cancers.

참고문헌 (Reference)

1 Ngoma T, "World Health Organization cancer priorities in developing countries" 17 (17): viii9-viii14, 2006

2 Cooper BS, "The economic cost of illness revisited" 39 : 21-36, 1976

3 Brown ML, "The burden of illness of cancer : economic cost and quality of life" 22 : 91-113, 2001

4 Khang YH, "Socioeconomic inequality in mortality using 12-year follow-up data from nationally representative surveys in South Korea" 15 : 51-, 2016

5 Lee SK, "Socio-economic, dietary, activity, nutrition and body weight transitions in South Korea" 6 : 665-674, 2003

6 Young JL Jr, "SEER summary staging manual - 2000. Codes and coding instructions"

7 Bradley CJ, "Productivity costs of cancer mortality in the United States : 2000-2020" 100 : 1763-1770, 2008

8 Romero Y, "National cancer control plans : a global analysis" 19 : e546-e555, 2018

9 Myong JP, "Impacts of household income and economic recession on participation in colorectal cancer screening in Korea" 13 : 1857-1862, 2012

10 GBD 2013 Mortality and Causes of Death Collaborators, "Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013 : a systematic analysis for the global burden of disease study 2013" 385 : 117-171, 2015

11 Kim K, "Factors influencing health-related quality of life among Korean cancer survivors" 26 : 81-87, 2017

12 Han KT, "Factors affecting the quality of life of Korean cancer survivors who return to the workplace" 15 : 8783-8788, 2014

13 Yabroff KR, "Economic burden of cancer in the United States : estimates, projections, and future research" 20 : 2006-2014, 2011

14 이광식, "Economic Burden of Cancer in Korea during 2000-2010" 대한암학회 47 (47): 387-398, 2015

15 Miura F, "Diagnosis of pancreatic cancer" 8 : 337-342, 2006

16 Ferlay J, "Cancer incidence and mortality worldwide : sources, methods and major patterns in GLOBOCAN 2012" 136 : E359-E386, 2015

17 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015" 대한암학회 50 (50): 303-316, 2018